TI
JAZZ icon

Tidal Investments’s Jazz Pharmaceuticals JAZZ Stock Holding History

Tidal Investments’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.6M Buy
19,413
+13,520
+229% +$2.36M 0.01% 935
2025
Q4 		$1M Buy
5,893
+671
+13% +$103K ﹤0.01% 1265
2025
Q3 		$688K Sell
5,222
-5,689
-52% -$682K ﹤0.01% 1398
2025
Q2 		$1.16M Sell
10,911
-3,010
-22% -$327K 0.01% 971
2025
Q1 		$1.73M Sell
13,921
-9,984
-42% -$1.3M 0.01% 755
2024
Q4 		$2.94M Buy
23,905
+3,028
+15% +$357K 0.02% 553
2024
Q3 		$2.33M Sell
20,877
-792
-4% -$86.8K 0.02% 575
2024
Q2 		$2.31M Buy
21,669
+5,014
+30% +$551K 0.03% 498
2024
Q1 		$2.01M Buy
16,655
+10,693
+179% +$1.31M 0.03% 526
2023
Q4 		$733K Buy
5,962
+264
+5% +$32.9K 0.02% 778
2023
Q3 		$738K Sell
5,698
-449
-7% -$59.8K 0.02% 656
2023
Q2 		$762K Buy
6,147
+695
+13% +$93.5K 0.02% 628
2023
Q1 		$798K Buy
5,452
+2,925
+116% +$433K 0.03% 574
2022
Q4 		$403K Buy
2,527
+562
+29% +$82.4K 0.02% 731
2022
Q3 		$262K Buy
+1,965
New +$299K 0.01% 822

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Tidal Investments's JAZZ Position: Q1 2026 in Review

Tidal Investments increased its Jazz Pharmaceuticals (JAZZ) stake by 229% in Q1 2026, buying an estimated $2.36M and bringing the position to 19,413 shares worth $3.6M. The position accounts for 0.01% of the portfolio, ranked #935.

Tidal Investments first reported a position in JAZZ in Q3 2022 and has held it in 15 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Tidal Investments held 19,413 shares of Jazz Pharmaceuticals worth $3.6M as of Q1 2026.
  • Tidal Investments bought 13,520 Jazz Pharmaceuticals shares in Q1 2026, an estimated $2.36M.
  • Jazz Pharmaceuticals made up 0.01% of Tidal Investments's portfolio in Q1 2026, its #935 holding.
  • Tidal Investments first reported a position in Jazz Pharmaceuticals in Q3 2022 and has held it in 15 quarters since.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Tidal Investments's 13F filing for Q1 2026, filed 15 May 2026.